New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. January has a funny way of making us ambitious.

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. ON THIS PAGE Featured Partner While Ozempic has been ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

The FDA has approved a pill form of the popular injectable obesity drug Wegovy. People on the highest dose dropped about 14 percent of their starting weight after 64 weeks, with a high number of ...

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program? That’s what Gov. Dan McKee’s fiscal year 2027 budget suggests.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. When HCA Healthcare, one ...

This randomized controlled trial shows that structured moderate-to-vigorous exercise, alone or combined with liraglutide, ...